1345.HK Stock Analysis
13
Uncovered
Shanghai Pioneer Holding Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
0.301
Dividend yield
2.31 %
Shares outstanding
1 190.38 B
China Pioneer Pharma Holdings Ltd. is an investment holding company, which engages in the manufacture, promotion, and sale of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 292 full-time employees. The company went IPO on 2013-11-05. The firm operates mainly through three segments. The Products Sold via the Provision of Channel Management Services segment is principally engaged in the sales of the Company's ophthalmic pharmaceutical products to customers through pipeline management arrangements. The Products Sold via the Provision of Comprehensive Marketing, Promotion and Channel Management Services segment is principally engaged in the sale of all of the Company's pharmaceutical products and medical devices to customers through comprehensive marketing, promotion and channel management arrangements. The Sales of Personal Protective Materials segment is mainly engaged in the sales of personal protective materials include masks, protective gloves and protective suits.